Support Portal

The pandemic imprinted a sense of purpose, urgency, and collaboration across the life sciences industry. With millions of lives and economic stability at st...

Data Provides Context and Meaning across the Clinical Trial Spectrum Three Saama clients, Len Rosenberg from The Leukemia & Lymphoma Society (LLS) and ...

It’s time to get more active around safety surveillance. Active drug safety surveillance has been a hot topic for some time, especially since the FDA Senti...

Medical product safety is critical for patients’ health and the success of a drug launched after R&D and clinical trials worth billions of dollars. Howe...

If there is one thing this year has taught me, it is that we are stronger and more resilient than we know. COVID-19 has proven to be a challenging obstacle ...

Prior to the pandemic, the pharmaceutical industry found itself in a difficult situation: A rising reliance on patient-centric and patient-directed data, hi...

When it comes to drug safety, waiting for reports from patients and their doctors just isn’t good enough. For decades, the FDA relied exclusively on patien...

In our efforts to accelerate drug development and advance the use of AI in pharma, Saama’s product team has been training machine learning models on CRF dat...

In the June 2020 issue of PharmaVOICE that showcases clinical trial solutions, I wrote an article about how the pandemic has catalyzed our industry around r...

A merger. An update. A pandemic. Our company, and our industry, are moving towards a more comprehensive vision of clinical data analysis. Read More...